Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Kaye

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humansM J Morris, H S Cox, G W Lambert, et al.
American Journal of Physiology. Renal Physiology|March 24, 2012
Evidence that renal arginine transport is impaired in spontaneously hypertensive ratsN W Rajapakse, S Kuruppu, I Hanchapola, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 1, 1995
Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humansM D Esler, G W Lambert, C Ferrier, et al.
Circulation|May 1, 1996
Cardiac sympathetic nerve function in congestive heart failureG Eisenhofer, P Friberg, B Rundqvist, et al.
The Journal of Biological Chemistry|June 16, 1995
Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytesJ L Balligand, L Kobzik, X Han, et al.
Circulation|January 15, 1995
Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressorsM D Esler, J M Thompson, D M Kaye, et al.
Journal of Cardiac Failure|December 1, 1996
The role of the NO pathway in the control of cardiac functionT W Smith, J L Balligand, D M Kaye, et al.
Journal of Molecular and Cellular Cardiology|May 11, 2007
The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivoR H Ritchie, J M Quinn, A H Cao, et al.
Blood Pressure|March 1, 1994
Monoaminergic neuronal activity in subcortical brain regions in essential hypertensionG W Lambert, C Ferrier, D M Kaye, et al.
Annals of the New York Academy of Sciences|July 12, 1995
Central nervous system norepinephrine turnover in essential hypertensionG W Lambert, C Ferrier, D M Kaye, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humansM J Morris, H S Cox, G W Lambert, et al.
American Journal of Physiology. Renal Physiology|March 24, 2012
Evidence that renal arginine transport is impaired in spontaneously hypertensive ratsN W Rajapakse, S Kuruppu, I Hanchapola, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 1, 1995
Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humansM D Esler, G W Lambert, C Ferrier, et al.
Circulation|May 1, 1996
Cardiac sympathetic nerve function in congestive heart failureG Eisenhofer, P Friberg, B Rundqvist, et al.
The Journal of Biological Chemistry|June 16, 1995
Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytesJ L Balligand, L Kobzik, X Han, et al.
Circulation|January 15, 1995
Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressorsM D Esler, J M Thompson, D M Kaye, et al.
Journal of Cardiac Failure|December 1, 1996
The role of the NO pathway in the control of cardiac functionT W Smith, J L Balligand, D M Kaye, et al.
Journal of Molecular and Cellular Cardiology|May 11, 2007
The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivoR H Ritchie, J M Quinn, A H Cao, et al.
Blood Pressure|March 1, 1994
Monoaminergic neuronal activity in subcortical brain regions in essential hypertensionG W Lambert, C Ferrier, D M Kaye, et al.
Annals of the New York Academy of Sciences|July 12, 1995
Central nervous system norepinephrine turnover in essential hypertensionG W Lambert, C Ferrier, D M Kaye, et al.
Pageof 8